Literature DB >> 7590434

Phospholipase A2 gene expression and activity in histologically normal ileal mucosa and in Crohn's ileitis.

I Lilja1, K Smedh, G Olaison, R Sjödahl, C Tagesson, C Gustafson-Svärd.   

Abstract

Increased activity of phospholipase A2 (PLA2) in the ileal mucosa may contribute to the inflammation in Crohn's disease. The results of this study showed that (a) three months after ileocolonic resection for Crohn's disease the neoterminal ileal mucosa showed endoscopically new inflammation and had higher PLA2 activity than at the time of the operation (n = 8); no such findings were seen in controls (n = 7), (b) histologically normal ileal mucosa (n = 3) contained mRNA for three isoforms of PLA2 (PLA2-I, PLA2-II, and cPLA2), but the amounts of PLA2-II mRNA clearly exceeded the amounts of mRNA for PLA2-I and cPLA2, (c) ileal mucosa from Crohn's patients (n = 2) contained higher values of PLA2-II mRNA than ileal mucosa from two controls, (d) ileal mucosa from Crohn's patients (n = 4) showed increased PLA2-II mRNA three months after ileocolonic resection. In conclusion, these results show that the predominating PLA2 mRNA in the human ileal mucosa is type II PLA2, and the increased synthesis of PLA2-II might be responsible for the increased PLA2 activity found in the ileal mucosa accompanying recurrent ileal inflammation in Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590434      PMCID: PMC1382819          DOI: 10.1136/gut.37.3.380

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Light microscopic immunohistochemical analysis of the distribution of group II phospholipase A2 in human digestive organs.

Authors:  H Kiyohara; H Egami; Y Shibata; K Murata; S Ohshima; M Ogawa
Journal:  J Histochem Cytochem       Date:  1992-11       Impact factor: 2.479

Review 2.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

3.  Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis.

Authors:  T Minami; H Tojo; Y Shinomura; S Tarui; M Okamoto
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

4.  Detection of arachidonoyl-selective phospholipase A2 in human neutrophil cytosol.

Authors:  C S Ramesha; D L Ives
Journal:  Biochim Biophys Acta       Date:  1993-05-20

5.  Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms.

Authors:  G Olaison; K Smedh; R Sjödahl
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

6.  A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP.

Authors:  J D Clark; L L Lin; R W Kriz; C S Ramesha; L A Sultzman; A Y Lin; N Milona; J L Knopf
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

7.  Purification and characterization of a phospholipase A2 from human ileal mucosa.

Authors:  T Minami; H Tojo; Y Shinomura; Y Matsuzawa; M Okamoto
Journal:  Biochim Biophys Acta       Date:  1993-10-13

8.  Structure and properties of a human non-pancreatic phospholipase A2.

Authors:  R M Kramer; C Hession; B Johansen; G Hayes; P McGray; E P Chow; R Tizard; R B Pepinsky
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

9.  Initiation of anastomotic recurrence of Crohn's disease after ileocolic resection. Onset proximal to the junction and preceded by increased phospholipase A2 activity.

Authors:  K Smedh; G Olaison; R Sjödahl
Journal:  Scand J Gastroenterol       Date:  1992-08       Impact factor: 2.423

10.  Macrophage colony stimulating factor activates phosphatidylcholine hydrolysis by cytoplasmic phospholipase A2.

Authors:  T Nakamura; L L Lin; S Kharbanda; J Knopf; D Kufe
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  13 in total

1.  A distal enhancer controls cytokine-dependent human cPLA2α gene expression.

Authors:  Justin S Bickford; Dawn E Beachy; Kimberly J Newsom; Sarah J Barilovits; John-David H Herlihy; Xiaolei Qiu; Jewell N Walters; Ning Li; Harry S Nick
Journal:  J Lipid Res       Date:  2013-04-02       Impact factor: 5.922

2.  Gene expression of group II phospholipase A2 in intestine in ulcerative colitis.

Authors:  M M Haapamäki; J M Grönroos; H Nurmi; K Alanen; M Kallajoki; T J Nevalainen
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

3.  Zinc (Zn2+) binds to and stimulates the activity of group I but not group II phospholipase A2.

Authors:  M Lindahl; C Tagesson
Journal:  Inflammation       Date:  1996-12       Impact factor: 4.092

4.  Group IIA phospholipase A2 mediates lung injury in intestinal ischemia-reperfusion.

Authors:  K Koike; Y Yamamoto; Y Hori; T Ono
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

5.  Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats.

Authors:  C Gustafson-Svärd; I Lilja; O Hallböök; R Sjödahl
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

6.  Distinct isoforms of phospholipase A2 mediate the ability of Salmonella enterica serotype typhimurium and Shigella flexneri to induce the transepithelial migration of neutrophils.

Authors:  Karen L Mumy; Jeffrey D Bien; Michael A Pazos; Karsten Gronert; Bryan P Hurley; Beth A McCormick
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

7.  Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2.

Authors:  M Lindahl; C Tagesson
Journal:  Inflammation       Date:  1997-06       Impact factor: 4.092

8.  sPLA2-IIa is an inflammatory mediator when the ocular surface is compromised.

Authors:  Dongmei Chen; Yi Wei; Xiaohong Li; Seth Epstein; J Mario Wolosin; Penny Asbell
Journal:  Exp Eye Res       Date:  2008-12-16       Impact factor: 3.467

9.  Computational modeling and in-vitro/in-silico correlation of phospholipid-based prodrugs for targeted drug delivery in inflammatory bowel disease.

Authors:  Arik Dahan; Milica Markovic; Shahar Keinan; Igor Kurnikov; Aaron Aponick; Ellen M Zimmermann; Shimon Ben-Shabat
Journal:  J Comput Aided Mol Des       Date:  2017-11-03       Impact factor: 3.686

Review 10.  The role of group IIA secretory phospholipase A2 (sPLA2-IIA) as a biomarker for the diagnosis of sepsis and bacterial infection in adults-A systematic review.

Authors:  Toh Leong Tan; Yew Yip Goh
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.